ProShare Advisors
KROS icon

ProShare Advisors’s Keros Therapeutics KROS Stock Holding History

ProShare Advisors’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,549
Closed -$167K – 2172
2024
Q4 		$167K Buy
10,549
+2,764
+36% +$144K ﹤0.01% 1938
2024
Q3 		$452K Buy
7,785
+2,118
+37% +$105K ﹤0.01% 1193
2024
Q2 		$259K Sell
5,667
-1,469
-21% -$78.9K ﹤0.01% 1391
2024
Q1 		$472K Buy
7,136
+1,496
+27% +$88.7K ﹤0.01% 1124
2023
Q4 		$224K Buy
+5,640
New +$177K ﹤0.01% 1576
2023
Q1 		– Sell
-4,753
Closed -$228K – 1857
2022
Q4 		$228K Buy
+4,753
New +$222K ﹤0.01% 1403
2022
Q2 		– Sell
-5,349
Closed -$291K – 1968
2022
Q1 		$291K Sell
5,349
-1,353
-20% -$69.5K ﹤0.01% 1649
2021
Q4 		$392K Sell
6,702
-284
-4% -$14.2K ﹤0.01% 1622
2021
Q3 		$276K Sell
6,986
-1,248
-15% -$44.4K ﹤0.01% 1607
2021
Q2 		$350K Buy
8,234
+1,479
+22% +$80.1K ﹤0.01% 1786
2021
Q1 		$416K Buy
6,755
+293
+5% +$18.6K ﹤0.01% 1571
2020
Q4 		$456K Buy
+6,462
New +$407K ﹤0.01% 1325

Other funds holding KROS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return